‘I just want to play tennis and focus on the tournament’, said the Polish world number 2 after being informed that the World Anti-Doping Agency considered the tennis player’s defense as ‘plausible’
received with relief, this Monday (20), the news that the World Anti-Doping Agency (Wada) decided not to appeal his situation. The entity considered the tennis player’s defense as “plausible”, which officially closes the case and allows her to resume her focus on tennis competitions. “Well, for sure, I’m pleased to be able to close the case and I can move on and finish this whole process, because I just want to play tennis and focus on the tournament”, declared the Polish world number 2 after beating the young German Eva Lys in the round of 16 of the , in Melbourne.
In August 2024, Swiatek tested positive for trimetazidine (TMZ), a substance that has sparked controversy. After a detailed analysis, ITIA determined that the contamination was accidental, resulting from the use of a medication to aid sleep. As a result, the athlete accepted a one-month suspension. Wada, upon assessing the situation, concluded that there were not sufficient grounds to take the case to the Court of Arbitration for Sport (CAS). This decision came as a relief to Swiatek, who can now focus on his performance on the court without the pressure of an ongoing lawsuit.
*Report produced with the help of AI
Published by Matheus Oliveira
